Neuphoria Therapeutics Inc. (NEUP)
NASDAQ: NEUP · Real-Time Price · USD
4.150
-0.210 (-4.82%)
At close: Feb 27, 2026, 4:00 PM EST
4.300
+0.150 (3.61%)
After-hours: Feb 27, 2026, 5:57 PM EST
Neuphoria Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Neuphoria Therapeutics stock have an average target of 21, with a low estimate of 7.00 and a high estimate of 35. The average target predicts an increase of 406.02% from the current stock price of 4.15.
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 5, 2025.
Analyst Ratings
The average analyst rating for Neuphoria Therapeutics stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $21 → $7 | Strong Buy | Maintains | $21 → $7 | +68.67% | Dec 5, 2025 |
| Maxim Group | Maxim Group | Strong Buy Maintains $18 → $35 | Strong Buy | Maintains | $18 → $35 | +743.37% | Sep 11, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $21 | Strong Buy | Reiterates | $21 | +406.02% | Aug 26, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $8 → $21 | Strong Buy | Maintains | $8 → $21 | +406.02% | Feb 4, 2025 |
Financial Forecast
Revenue This Year
n/a
from 15.65M
Revenue Next Year
n/a
EPS This Year
-5.58
from -0.23
EPS Next Year
-4.43
from -5.58
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | n/a | n/a | |||
| Avg | n/a | n/a | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -4.27 | -2.55 | |
| Avg | -5.58 | -4.43 | |
| Low | -6.93 | -5.23 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.